Drug intelligence / Profile preview

Vacuna Polimerizada

Development stage
Unknown
Lead developer
Alergo Pharma
Modality
Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Vacuna Polimerizada is an injectable allergen immunotherapy product developed by Alergo Pharma for the treatment of allergic diseases, including allergic rhinitis, allergic asthma, and allergic conjunctivitis. The vaccine is composed of allergen extracts that have undergone chemical modification through polymerization using agents such as glutaraldehyde or formaldehyde. This polymerization process creates high-molecular-weight complexes, often referred to as allergoids, which possess significantly reduced IgE-binding capacity compared to native extracts. This reduction in immediate allergenicity allows for the administration of higher allergen doses with a lower risk of systemic allergic reactions. The vaccine preserves the essential T-cell epitopes required to stimulate the immune system, thereby inducing long-term immune tolerance and modifying the underlying course of the allergic disease through repeated subcutaneous administration.

Brand names
Vacuna Polimerizada
Other names
Alergo Pharma polymerized vaccinePolymerized allergen vaccineInjectable polymerized vaccineChemically modified allergen extract

Beyond the preview

Go deeper on Vacuna Polimerizada.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vacuna Polimerizada.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call